{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:22:47Z","timestamp":1778588567095,"version":"3.51.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13321-017-0249-4","type":"journal-article","created":{"date-parts":[[2017,12,30]],"date-time":"2017-12-30T15:40:43Z","timestamp":1514648443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Computer-aided design of multi-target ligands at A1R, A2AR and PDE10A, key proteins in neurodegenerative diseases"],"prefix":"10.1186","volume":"9","author":[{"given":"Leen","family":"Kalash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Val","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhonny","family":"Azuaje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda I.","family":"Loza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azedine","family":"Zoufir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis","family":"Mervin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Ladds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Brea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Glen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddy","family":"Sotelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6683-7546","authenticated-orcid":false,"given":"Andreas","family":"Bender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,30]]},"reference":[{"key":"249_CR1","first-page":"78","volume":"1","author":"GG Kovacs","year":"2014","unstructured":"Kovacs GG (2014) Current concepts of neurodegenrative diseases. Eur Med J 1:78\u201386","journal-title":"Eur Med J"},{"key":"249_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1474-4422(04)00740-9","volume":"3","author":"AE Lang","year":"2004","unstructured":"Lang AE, Obeso JA (2004) Personal view challenges in Parkinson\u2019s disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 3:309\u2013316","journal-title":"Lancet Neurol"},{"key":"249_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","volume":"79","author":"S Latini","year":"2001","unstructured":"Latini S, Pedata F (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79:463\u2013484","journal-title":"J Neurochem"},{"key":"249_CR4","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1021\/jm201640m","volume":"55","author":"BC Shook","year":"2012","unstructured":"Shook BC, Rassnick S, Wallace N, Crooke J, Ault M, Chakravarty D, Barbay JK, Wang A, Powell MT, Leonard K, Alford V, Scannevin RH, Carroll K, Lampron L, Westover L, Lim H, Russell R, Branum S, Wells KM, Damon S, Youells S, Li X, Beauchamp DA, Rhodes K, Jackson PF (2012) Design and characterization of optimized adenosine A2A\/A1 receptor antagonists for the treatment of Parkinson\u2019s disease. J Med Chem 55:1402\u20131417","journal-title":"J Med Chem"},{"key":"249_CR5","doi-asserted-by":"publisher","first-page":"9356","DOI":"10.1128\/MCB.20.24.9356-9363.2000","volume":"20","author":"M Li","year":"2000","unstructured":"Li M, Wang X, Meintzer MKAY, Laessig T, Birnbaum MJ, Heidenreich KIMA (2000) Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3 \u03b2. Mol Cell Biol 20:9356\u20139363","journal-title":"Mol Cell Biol"},{"key":"249_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1124\/jpet.107.132910","volume":"325","author":"CJ Schmidt","year":"2008","unstructured":"Schmidt CJ, Chapin DS, Cianfrogna J, Corman ML, Hajos M, Harms JF, Hoffman WE, Lebel LA, McCarthy SA, Nelson FR, Proulx-LaFrance C, Majchrzak MJ, Ramirez AD, Schmidt K, Seymour PA, Siuciak JA, Tingley FD, Williams RD, Verhoest PR, Menniti FS (2008) Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia. J Pharmacol Exp Ther 325:681\u2013690","journal-title":"J Pharmacol Exp Ther"},{"key":"249_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.nbd.2009.02.014","volume":"34","author":"C Giamp\u00e0","year":"2009","unstructured":"Giamp\u00e0 C, Patassini S, Borreca A, Laurenti D, Marullo F, Bernardi G, Menniti FS, Fusco FR (2009) Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington\u2019s disease. Neurobiol Dis 34:450\u2013456","journal-title":"Neurobiol Dis"},{"key":"249_CR8","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1093\/brain\/awv219","volume":"138","author":"F Niccolini","year":"2015","unstructured":"Niccolini F, Foltynie T, Reis Marques T, Muhlert N, Tziortzi AC, Searle GE, Natesan S, Kapur S, Rabiner EA, Gunn RN, Piccini P, Politis M (2015) Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson\u2019s disease. Brain 138:3003\u20133015","journal-title":"Brain"},{"key":"249_CR9","first-page":"6451","volume":"267","author":"GL Stiles","year":"1992","unstructured":"Stiles GL (1992) Adenosine receptors. JBiolChem 267:6451\u20136454","journal-title":"JBiolChem"},{"key":"249_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1182\/blood-2009-11-252668","volume":"116","author":"RJ Rickles","year":"2010","unstructured":"Rickles RJ, Pierce LT, Giordano TP, Tam WF, Mcmillin DW, Delmore J, Laubach JP, Borisy AA, Richardson PG, Lee MS (2010) Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies. Blood 116:593\u2013603","journal-title":"Blood"},{"key":"249_CR11","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.bbamem.2010.12.001","volume":"1808","author":"CV Gomes","year":"2011","unstructured":"Gomes CV, Kaster MP, Tom\u00e9 AR, Agostinho PM, Cunha RA (2011) Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochim Biophys Acta 1808:1380\u20131399","journal-title":"Biochim Biophys Acta"},{"key":"249_CR12","first-page":"1","volume":"8","author":"M Arooj","year":"2013","unstructured":"Arooj M, Sakkiah S, Cao GP, Lee KW (2013) An innovative strategy for dual inhibitor design and its application in dual inhibition of human thymidylate synthase and dihydrofolate reductase enzymes. PLoS ONE 8:1\u201315","journal-title":"PLoS ONE"},{"key":"249_CR13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S1359-6446(04)03163-0","volume":"9","author":"R Morphy","year":"2004","unstructured":"Morphy R, Kay C, Rankovic Z, Morphy R (2004) From magic bullets to designed multiple ligands. Drug Discov Today 9:641\u2013651","journal-title":"Drug Discov Today"},{"key":"249_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","volume":"26","author":"P Csermely","year":"2005","unstructured":"Csermely P, \u00c1goston V, Pongor S (2005) The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 26:178\u2013182","journal-title":"Trends Pharmacol Sci"},{"key":"249_CR15","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.7150\/ijbs.11595","volume":"11","author":"M Khan","year":"2015","unstructured":"Khan M, Maryam A, Qazi JI, Ma T (2015) Targeting apoptosis and multiple signaling pathways with Icariside II in cancer cells. Int J Biol Sci 11:1100\u20131112","journal-title":"Int J Biol Sci"},{"key":"249_CR16","doi-asserted-by":"publisher","first-page":"9646","DOI":"10.18632\/oncotarget.3917","volume":"6","author":"I Amelio","year":"2015","unstructured":"Amelio I, Landr\u00e9 V, Knight RA, Lisitsa A, Melino G, Antonov AV (2015) Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems. Oncotarget 6:9646\u20139656","journal-title":"Oncotarget"},{"key":"249_CR17","doi-asserted-by":"publisher","first-page":"8955","DOI":"10.1021\/jm400856t","volume":"56","author":"J Peters","year":"2013","unstructured":"Peters J (2013) Polypharmacology\u2014foe or friend? J Med Chem 56:8955\u20138971","journal-title":"J Med Chem"},{"key":"249_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nature11691","volume":"492","author":"J Besnard","year":"2012","unstructured":"Besnard J, Ruda GF, Setola V, Abecassis K, Ramona M, Huang X, Norval S, Sassano MF, Shin AI, Webster A, Simeons FRC, Stojanovski L, Prat A, Seidah NG, Constam DB, Bickerton GR, Read KD, Wetsel WC, Ian H, Roth BL, Hopkins AL (2012) Automated design of ligands to polypharmacological profiles. Nature 492:1\u201317","journal-title":"Nature"},{"key":"249_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s11095-010-0065-2","volume":"27","author":"XH Ma","year":"2010","unstructured":"Ma XH, Shi Z, Tan C, Jiang Y, Go ML, Low BC, Chen YZ (2010) In-silico approaches to multi-target drug discovery computer aided multi-target drug design, multi-target virtual screening. Pharm Res 27:739\u2013749","journal-title":"Pharm Res"},{"key":"249_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1359-6446(02)02463-7","volume":"7","author":"S Huang","year":"2002","unstructured":"Huang S (2002) Rational drug discovery: what can we learn from regulatory networks? Drug Discov Today 7:163\u2013169","journal-title":"Drug Discov Today"},{"key":"249_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2016.00265","volume":"10","author":"K Nikolic","year":"2016","unstructured":"Nikolic K, Mavridis L, Djikic T, Vucicevic J, Agbaba D, Yelekci K, Mitchell JBO (2016) Drug design for CNS diseases: polypharmacological profiling of compounds using cheminformatic, 3D-QSAR and virtual screening methodologies. Front Neurosci 10:1\u201321","journal-title":"Front Neurosci"},{"key":"249_CR22","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/cmdc.201600161","volume":"11","author":"M Laura","year":"2016","unstructured":"Laura M, Cavalli A (2016) Multitarget drug discovery and polypharmacology. ChemMedChem 11:1190\u20131192","journal-title":"ChemMedChem"},{"key":"249_CR23","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.jprot.2011.05.011","volume":"74","author":"A Koutsoukas","year":"2011","unstructured":"Koutsoukas A, Simms B, Kirchmair J, Bond PJ, Whitmore AV, Zimmer S, Young MP, Jenkins JL, Glick M, Glen RC, Bender A (2011) From in silico target prediction to multi-target drug design: current databases, methods and applications. J Proteomics 74:2554\u20132574","journal-title":"J Proteomics"},{"key":"249_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-015-0098-y","volume":"7","author":"LH Mervin","year":"2015","unstructured":"Mervin LH, Afzal AM, Drakakis G, Lewis R, Engkvist O, Bender A (2015) Target prediction utilising negative bioactivity data covering large chemical space. J Cheminform 7:1\u201316","journal-title":"J Cheminform"},{"key":"249_CR25","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/cmdc.201500418","volume":"11","author":"D Dolles","year":"2016","unstructured":"Dolles D, Nimczick M, Scheiner M, Ramler J, Stadtm\u00fcller P, Sawatzky E, Drakopoulos A, Sotriffer C, Wittmann H, Strasser A, Decker M (2016) Aminobenzimidazoles and structural isomers as templates for dual-acting butyrylcholinesterase inhibitors and hCB2R ligands to combat neurodegenerative disorders. ChemMedChem 11:1270\u20131283","journal-title":"ChemMedChem"},{"key":"249_CR26","unstructured":"Molecular Operating Environment (MOE) (2013) Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2016"},{"key":"249_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1021\/ci970429i","volume":"38","author":"XQ Lewell","year":"1998","unstructured":"Lewell XQ, Judd DB, Watson SP, Hann MM (1998) RECAP-retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J Chem Inf Comput Sci 38:511\u2013522","journal-title":"J Chem Inf Comput Sci"},{"key":"249_CR28","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.2174\/0929867023368719","volume":"9","author":"L Weber","year":"2002","unstructured":"Weber L (2002) The application of multi-component reactions in drug discovery. Curr Med Chem 9:2085\u20132093","journal-title":"Curr Med Chem"},{"key":"249_CR29","doi-asserted-by":"publisher","first-page":"5605","DOI":"10.1016\/j.bmc.2006.04.035","volume":"14","author":"CC Musonda","year":"2006","unstructured":"Musonda CC, Gut J, Rosenthal PJ, Yardley V, Carvalho de Souza RC, Chibale K (2006) Application of multicomponent reactions to antimalarial drug discovery. Part 2: new antiplasmodial and antitrypanosomal 4-aminoquinoline \u03b3- and \u03b4-lactams via a \u2018catch and release\u2019 protocol. Bioorganic Med Chem 14:5605\u20135615","journal-title":"Bioorganic Med Chem"},{"key":"249_CR30","first-page":"1","volume":"40","author":"A Gaulton","year":"2011","unstructured":"Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP (2011) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:1\u20138","journal-title":"Nucleic Acids Res"},{"key":"249_CR31","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/minf.201300102","volume":"32","author":"S Liggi","year":"2013","unstructured":"Liggi S, Drakakis G, Hendry AE, Hanson KM, Brewerton SC, Wheeler GN, Bodkin MJ, Evans DA, Bender A (2013) Extensions to in silico bioactivity predictions using pathway annotations and differential pharmacology analysis: application to xenopus laevis phenotypic readouts. Mol Inform 32:1009\u20131024","journal-title":"Mol Inform"},{"key":"249_CR32","unstructured":"Jones E, Oliphant T, Peterson P (2001) SciPy: open source scientific tools for python. http:\/\/www.scipy.org\/ . Accessed 27 Feb 2017"},{"key":"249_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1126\/science.1219218","volume":"337","author":"W Liu","year":"2012","unstructured":"Liu W, Chun E, Thompson AA, Chubukov P, Xu F, Han GW, Roth CB, Heitman LH, Ijzerman AP, Cherezov V, Stevens RC (2012) Structural basis for allosteric regulation of GPCRs by sodium ions. Science 337:232\u2013236","journal-title":"Science"},{"key":"249_CR34","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.bmcl.2012.01.086","volume":"22","author":"E Hu","year":"2012","unstructured":"Hu E, Kunz RK, Rumfelt S, Chen N, B\u00fcrli R, Li C, Andrews KL, Zhang J, Chmait S, Kogan J, Lindstrom M, Hitchcock SA, Treanor J (2012) Discovery of potent, selective, and metabolically stable 4-(pyridin-3-yl) cinnolines as novel phosphodiesterase 10A (PDE10A) inhibitors. Bioorg Med Chem Lett 22:2262\u20132265","journal-title":"Bioorg Med Chem Lett"},{"key":"249_CR35","doi-asserted-by":"publisher","first-page":"50100","DOI":"10.1039\/C6RA12299J","volume":"6","author":"OS Ch","year":"2016","unstructured":"Ch OS, Cn IC, Ali M, Kiafar M, Yarie M, Taherpour A (2016) Experimental and Theoretical Studies of the nanostructured {Fe3O4@SiO2@(CH2)3Im}C(CN)3 catalyst for 2-amino-3-cyanopyridine preparation via an anomeric based oxidation. RSC Adv 6:50100\u201350111","journal-title":"RSC Adv"},{"key":"249_CR36","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1021\/jm701594y","volume":"51","author":"M Mantri","year":"2008","unstructured":"Mantri M, De Graaf O, Van Veldhoven J, Go A, Mulder-krieger T, Link R, De Vries H, Beukers MW, Brussee J, Ijzerman AP (2008) 2-amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists. J Med Chem 51:4449\u20134455","journal-title":"J Med Chem"},{"key":"249_CR37","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.tetlet.2016.03.020","volume":"57","author":"D Khalili","year":"2016","unstructured":"Khalili D (2016) Graphene oxide: a reusable and metal-free carbocatalyst for the one-pot synthesis of 2-amino-3-cyanopyridines in water. Tetrahedron Lett 57:1721\u20131723","journal-title":"Tetrahedron Lett"},{"key":"249_CR38","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ultsonch.2012.01.005","volume":"19","author":"J Safari","year":"2012","unstructured":"Safari J, Hossein S, Dehghan S (2012) Ultrasound-promoted an efficient method for one-pot synthesis of 2-amino-4,6-diphenylnicotinonitriles in water: a rapid procedure without catalyst. Ultrason Sonochem 19:1061\u20131069","journal-title":"Ultrason Sonochem"},{"key":"249_CR39","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53:2719\u20132740","journal-title":"J Med Chem"},{"key":"249_CR40","doi-asserted-by":"publisher","first-page":"W200","DOI":"10.1093\/nar\/gkv353","volume":"43","author":"D Lagorce","year":"2015","unstructured":"Lagorce D, Sperandio O, Baell JB, Miteva MA, Villoutreix BO (2015) FAF-Drugs3: a web server for compound property calculation and chemical library design. Nucleic Acids Res 43:W200\u2013W207","journal-title":"Nucleic Acids Res"},{"key":"249_CR41","doi-asserted-by":"publisher","first-page":"8292","DOI":"10.1021\/acs.jmedchem.5b01240","volume":"58","author":"VSP Lingam","year":"2015","unstructured":"Lingam VSP, Dahale Dnyaneshwar H, Rathi Vijay E, Shingote YB, Thakur RR, Mindhe AS, Kummari S, Khairatkar-joshi N, Bajpai M, Shah DM, Sapalya RS, Gullapalli S, Gupta PK, Gudi GS, Jadhav SB, Pattem R, Thomas A (2015) Design, synthesis, and pharmacological evaluation of 5,6- disubstituted pyridin-2(1H)-one derivatives as phosphodiesterase 10A (PDE10A) antagonists. J Med Chem 58:8292\u20138308","journal-title":"J Med Chem"},{"key":"249_CR42","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1016\/j.bmc.2009.06.063","volume":"17","author":"AH Abadi","year":"2009","unstructured":"Abadi AH, Ibrahim TM, Abouzid KM, Lehmann J, Tinsley HN, Gary BD, Piazza GA (2009) Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors. Bioorg Med Chem 17:5974\u20135982","journal-title":"Bioorg Med Chem"},{"key":"249_CR43","doi-asserted-by":"publisher","first-page":"7888","DOI":"10.1021\/acs.jmedchem.5b00983","volume":"58","author":"WD Shipe","year":"2015","unstructured":"Shipe WD, Sharik SS, Barrow JC, Mcgaughey GB, Theberge CR, Uslaner JM, Yan Y, Renger JJ, Smith SM, Coleman PJ, Cox CD (2015) Discovery and optimization of a series of pyrimidine-based phosphodiesterase 10A (PDE10A) inhibitors through fragment screening, structure-based design, and parallel synthesis. J Med Chem 58:7888\u20137894","journal-title":"J Med Chem"},{"key":"249_CR44","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1016\/j.bmcl.2016.07.054","volume":"26","author":"SK Meegalla","year":"2016","unstructured":"Meegalla SK, Huang H, Illig CR, Parks D, Chen J, Lee Y, Wilson K, Patel S, Cheung W, Lu T, Kirchner T, Askari H, Geisler J, Patch R, Gibbs A, Rady B, Connelly M, Player M (2016) Discovery of novel potent imidazo [1,2-b] pyridazine PDE10A inhibitors. Bioorg Med Chem Lett 26:4216\u20134222","journal-title":"Bioorg Med Chem Lett"},{"key":"249_CR45","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bmcl.2015.11.013","volume":"26","author":"IT Raheem","year":"2016","unstructured":"Raheem IT, Schreier JD, Fuerst J, Gantert L, Hostetler E, Huszar S, Joshi A, Kandebo M, Kim S, Li J, Ma B, McGaughey G, Sharma S, Shipe W, Uslaner J, Vandeveer G, Yan Y, Renger J, Smith S, Coleman P, Cox C (2016) Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia. Bioorg Med Chem Lett 26:126\u2013132","journal-title":"Bioorg Med Chem Lett"},{"key":"249_CR46","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1016\/j.bmc.2016.05.049","volume":"24","author":"M Yoshikawa","year":"2016","unstructured":"Yoshikawa M, Hitaka T, Hasui T, Fushimi M, Kunitomo J, Kokubo H, Oki H, Nakashima K, Taniguchi T (2016) Design and synthesis of potent and selective pyridazin-4(1H)-one-based PDE10A inhibitors interacting with Tyr683 in the PDE10A selectivity pocket. Bioorg Med Chem 24:3447\u20133455","journal-title":"Bioorg Med Chem"},{"key":"249_CR47","doi-asserted-by":"publisher","first-page":"7621","DOI":"10.1021\/jm2009138","volume":"54","author":"MS Malamas","year":"2011","unstructured":"Malamas MS, Ni Y, Erdei J, Stange H, Schindler R, Lankau H, Grunwald C, Fan K, Parris K, Langen B, Egerland U, Hage T, Marquis K, Grauer S, Brennan J, Navarra R, Graf R, Harrison B, Robichaud A, Kronbach T, Pangalos M, Hoefgen N, Brandon N (2011) Highly potent, selective, and orally active phosphodiesterase 10A inhibitors. J Med Chem 54:7621\u20137638","journal-title":"J Med Chem"},{"key":"249_CR48","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1021\/acs.jmedchem.5b01875","volume":"59","author":"B Kuhn","year":"2016","unstructured":"Kuhn B, Guba W, Banner D, Bissantz C, Ceccarelli S, Haap W, K\u00f6rner M, Kuglstatter A, Lerner C, Mattei P, Neidhart W, Pinard E, Rudolph M, Schulz-gasch T, Woltering T, Stahl M (2016) A real-world perspective on molecular design. J Med Chem 59:4087\u20134102","journal-title":"J Med Chem"},{"key":"249_CR49","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1126\/science.1164772","volume":"322","author":"V Jaakola","year":"2008","unstructured":"Jaakola V, Griffith M, Hanson M, Cherezov V, Chien E, Lane J, Ijzerman A, Stevens R (2008) The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322:1211\u20131218","journal-title":"Science"},{"key":"249_CR50","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1021\/acs.jmedchem.6b00653","volume":"59","author":"E Segala","year":"2016","unstructured":"Segala E, Guo D, Cheng RKY, Bortolato A, Deflorian F, Dor\u00e9 A, Errey J, Heitman L, Ijzerman A, Marshall F, Cooke R (2016) Controlling the dissociation of ligands from the adenosine A2A receptor through modulation of salt bridge strength. J Med Chem 59:6470\u20136479","journal-title":"J Med Chem"},{"key":"249_CR51","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1021\/acs.jmedchem.5b01402","volume":"59","author":"A Knight","year":"2016","unstructured":"Knight A, Hemmings JL, Win I, Leuenberger M, Frattini E, Frenguelli BG, Dowell SJ, Lochner M, Ladds G (2016) Discovery of novel adenosine receptor agonists that exhibit subtype selectivity. J Med Chem 59:947\u2013964","journal-title":"J Med Chem"},{"key":"249_CR52","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1124\/mol.116.105007","volume":"90","author":"ATN Nguyen","year":"2016","unstructured":"Nguyen ATN, Baltos J, Thomas T, Nguyen T, Munoz L, Gregory K, White P, Sexton P, Christopoulos A, May L (2016) Extracellular loop 2 of the adenosine A1 receptor has a key role in orthosteric ligand affinity and agonist efficacy. Mol Pharmacol 90:703\u2013714","journal-title":"Mol Pharmacol"},{"key":"249_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nbd.2009.07.033","volume":"37","author":"P Jeffrey","year":"2010","unstructured":"Jeffrey P, Summer S (2010) Neurobiology of disease assessment of the blood\u2013brain barrier in CNS drug discovery. Neurobiol Dis J 37:33\u201337","journal-title":"Neurobiol Dis J"},{"key":"249_CR54","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci500588j","volume":"55","author":"T Sander","year":"2015","unstructured":"Sander T, Freyss J, von Korff M, Rufener C (2015) DataWarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model 55:460\u2013473","journal-title":"J Chem Inf Model"},{"key":"249_CR55","unstructured":"RDKit: Cheminformatics and Machine Learning Software (2013) http:\/\/www.rdkit.org . Accessed 27 Feb 2017"},{"key":"249_CR56","unstructured":"ChemAxon Standardizer. https:\/\/www.chemaxon.com\/products\/standardizer . Accessed 27 Feb 2017"},{"key":"249_CR57","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750\u20131759","journal-title":"J Med Chem"},{"key":"249_CR58","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234","journal-title":"J Comput Aided Mol Des"},{"key":"249_CR59","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1021\/jm100843z","volume":"54","author":"V Yaziji","year":"2011","unstructured":"Yaziji V, Rodriguez D, Gutierrez-de-Terran H, Coelho A, Caamano O, Garcia-Mera X, Brea J, Loza MI, Cadavid MI, Sotelo E (2011) Pyrimidine derivatives as potent and selective A3 adenosine receptor antagonists. J Med Chem 54:457\u2013471","journal-title":"J Med Chem"},{"key":"249_CR60","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","volume":"22","author":"JD Thompson","year":"1994","unstructured":"Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673\u20134680","journal-title":"Nucleic Acids Res"},{"key":"249_CR61","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrd2877","volume":"8","author":"CLB Iii","year":"2009","unstructured":"Iii CLB, Dixon JS, Moult J, Stevens RC (2009) Community-wide assessment of GPCR structure modelling and ligand docking: GPCR dock 2008. Nat Rev Drug Discov 8:455\u2013463","journal-title":"Nat Rev Drug Discov"},{"key":"249_CR62","unstructured":"Schr\u00f6dinger Release 2016-4 (2016) LigPrep, Schr\u00f6dinger, LLC, New York"},{"key":"249_CR63","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley JC, Cholleti A, Frye LL, Greenwood JR, Timlin MR, Uchimaya M (2007) Epik: a software program for pKa prediction and protonation state generation for drug-like molecules. J Comput Aided Mol Des 21:681\u2013691","journal-title":"J Comput Aided Mol Des"},{"key":"249_CR64","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1021\/jm4011669","volume":"57","author":"M de Lera Ruiz","year":"2013","unstructured":"de Lera Ruiz M, Lim Y-H, Junying Z (2013) Adenosine A2A receptor as a drug discovery target. J Med Chem 57:3623\u20133650","journal-title":"J Med Chem"},{"key":"249_CR65","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1016\/j.ejmech.2011.05.023","volume":"46","author":"A Drabczy\u0144ska","year":"2011","unstructured":"Drabczy\u0144ska A, Yuzlenko O, K\u00f6se M, Paskaleva M, Schiedel AC, Karolak-Wojciechowska J, Handzlik J, Karcz T, Kuder K, M\u00fcller CE, Kie\u0107-Kononowicz K (2011) Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones. Eur J Med Chem 46:3590\u20133607","journal-title":"Eur J Med Chem"},{"key":"249_CR66","unstructured":"R Core Team (2016) R: A language and environment for statistical computing (version 3.2.4)"},{"key":"249_CR67","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1002\/ejoc.201500866","volume":"28","author":"N Khunnawutmanotham","year":"2015","unstructured":"Khunnawutmanotham N, Sahakitpichan P (2015) Divergent total syntheses to azafluoranthene and dehydroaporphine alkaloids. Eur J Org Chem 28:6324\u20136332","journal-title":"Eur J Org Chem"},{"key":"249_CR68","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1021\/jo00312a020","volume":"55","author":"P Molina","year":"1990","unstructured":"Molina P, Alajarin M, Vidal A (1990) Synthesis of isoquinoline derivatives. J Org Chem 55:6140\u20136147","journal-title":"J Org Chem"},{"key":"249_CR69","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejmech.2015.10.028","volume":"107","author":"S Wagner","year":"2016","unstructured":"Wagner S, Scheunemann M, Dipper K, Egerland U, Hoefgen N, Steinbach J, Burst P (2016) Development of highly potent phosphodiesterase 10A (PDE10A) inhibitors: synthesis and in vitro evaluation of 1, 8-dipyridinyl- and 1-pyridinyl-substituted imidazo [1, 5-a] quinoxalines. Eur J Med Chem 107:97\u2013108","journal-title":"Eur J Med Chem"},{"key":"249_CR70","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1021\/jm030217e","volume":"47","author":"P Chen","year":"2004","unstructured":"Chen P, Doweyko AM, Norris D, Gu HH, Spergel SH, Das J, Moquin RV, Lin J, Wityak J, Iwanowicz EJ, Mcintyre KW, Shuster DJ, Behnia K, Chong S, De Fex H, Pang S, Pitt S, Shen DR, Thrall S, Stanley P, Kocy OR, Witmer MR, Kanner SB, Schieven GL, Barrish JC (2004) Imidazoquinoxaline Src-family kinase p56Lck inhibitors: SAR, QSAR, and the discovery of (S)-N-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)Imidazo-[1,5-a]pyrido[3,2-e] pyrazin-6-amine (BMS-279700) as a Potent and Orally active inhibitor with excellent in vivo antiinflammatory activity. J Med Chem 47:4517\u20134529","journal-title":"J Med Chem"},{"key":"249_CR71","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1021\/jm501651a","volume":"58","author":"JM Bartolome","year":"2015","unstructured":"Bartolome JM, De Diego SAA, Artola M, Delgado F, Delgado O, Mart CM, Pena MA, Tong HM, Van Gool M, Alonso JM, Fontana A, Macdonald GJ, Megens A, Langlois X, Somers M, Vanhoof G, Conde-ceide S (2015) Identification of a novel orally bioavailable phosphodiesterase 10A (PDE10A) inhibitor with efficacy in animal models of schizophrenia. J Med Chem 58:978\u2013993","journal-title":"J Med Chem"},{"key":"249_CR72","doi-asserted-by":"publisher","first-page":"7621","DOI":"10.1021\/jm2009138","volume":"54","author":"MS Malamas","year":"2011","unstructured":"Malamas MS, Ni Y, Erdei J, Stange H, Schindler R, Lankau H, Grunwald C, Fan KY, Parris K, Langen B, Egerland U, Hage T, Marquis KL, Grauer S, Brennan J, Navarra R, Graf R, Harrison BL, Robichaud A (2011) Highly potent, selective, and orally active phosphodiesterase\u00a010A inhibitors. J Med Chem 54:7621\u20137638","journal-title":"J Med Chem"},{"key":"249_CR73","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.bmcl.2006.11.083","volume":"17","author":"BR Neustadt","year":"2007","unstructured":"Neustadt BR, Hao J, Lindo N, Greenlee WJ, Stamford AW, Tulshian D, Ongini E, Hunter J, Monopoli A, Bertorelli R, Foster C, Arik L, Lachowicz J, Feng K (2007) Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines. Bioorg Med Chem Lett 17:1376\u20131380","journal-title":"Bioorg Med Chem Lett"},{"key":"249_CR74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11302-007-9058-y","volume":"4","author":"C Bolcato","year":"2008","unstructured":"Bolcato C, Cusan C, Pastorin G, Spalluto G, Cacciari B, Klotz KN, Morizzo E, Moro S (2008) Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes. Purinergic Signal 4:39\u201346","journal-title":"Purinergic Signal"},{"key":"249_CR75","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1016\/j.bmcl.2011.04.067","volume":"21","author":"J Kehler","year":"2011","unstructured":"Kehler J, Ritzen A, Langg\u00e5rd M, Leth S, Farah MM, Bundgaard C, Tornby C, Nielsen J, Paul J (2011) Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors. Bioorg Med Chem Lett 21:3738\u20133742","journal-title":"Bioorg Med Chem Lett"},{"key":"249_CR76","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s00706-015-1456-1","volume":"146","author":"M Zadpour","year":"2015","unstructured":"Zadpour M, Behbahani FK (2015) Iron (III) phosphate as a green and reusable catalyst for the synthesis of 4,6-disubstituted 2-aminopyridine-3-carbonitriles. Monatsh Chem 146:1865\u20131869","journal-title":"Monatsh Chem"},{"key":"249_CR77","first-page":"182","volume":"7","author":"PU Patoliya","year":"2015","unstructured":"Patoliya PU, Gohel VP, Purohit DM, Patolia VN (2015) Synthesis and biological evaluation of some new cyano pyridine derivatives. J Chem Pharm Res 7:182\u2013186","journal-title":"J Chem Pharm Res"},{"key":"249_CR78","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1021\/jm031143+","volume":"47","author":"MP Bosch","year":"2004","unstructured":"Bosch MP, Campos F, Niubo I, Rosell G, Diaz JL, Brea J, Loza MI, Guerrero A (2004) Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor. J Med Chem 47:4041\u20134053","journal-title":"J Med Chem"},{"key":"249_CR79","doi-asserted-by":"crossref","unstructured":"Motulsky H, Christopoulos A (2004) Fitting models to biological data using linear and nonlinear regression. A practical guide to curve fitting","DOI":"10.1093\/oso\/9780195171792.001.0001"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-017-0249-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13321-017-0249-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-017-0249-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T06:09:44Z","timestamp":1719727784000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-017-0249-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["249"],"URL":"https:\/\/doi.org\/10.1186\/s13321-017-0249-4","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"20 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"67"}}